Burns J W & CO Inc Adma Biologics, Inc. Transaction History

Burns J W & CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 12, 2021	SELL	$1.8 - $2.56 $27,450 - $39,040	-15,250 Closed	0 $0
Q3 2020 Oct 06, 2020	SELL	$2.04 - $3.74 $12,750 - $23,375	-6,250 Reduced 29.07%	15,250 $36,000
Q1 2020 Apr 06, 2020	BUY	$1.5 - $4.59 $8,250 - $25,245	5,500 Added 34.38%	21,500 $62,000
Q4 2019 Jan 07, 2020	BUY	$3.89 - $5.15 $5,835 - $7,725	1,500 Added 10.34%	16,000 $64,000
Q1 2019 Apr 02, 2019	BUY	$2.61 - $4.35 $37,845 - $63,074	14,500 New	14,500 $55,000

317

189M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.23B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Burns J W & CO Inc with notifications on news.